DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $24,809,000 | -62.5% | 251,405 | -62.8% | 0.09% | -63.6% |
| Q1 2018 | $66,236,000 | -12.8% | 676,493 | -17.3% | 0.25% | -14.2% |
| Q4 2017 | $75,969,000 | -19.1% | 818,451 | -25.2% | 0.30% | -12.2% |
| Q3 2017 | $93,850,000 | -34.9% | 1,094,074 | -36.0% | 0.34% | -36.0% |
| Q2 2017 | $144,248,000 | +4.7% | 1,709,301 | +6.1% | 0.52% | +1.0% |
| Q1 2017 | $137,794,000 | +6.8% | 1,611,057 | -2.8% | 0.52% | +1.0% |
| Q4 2016 | $129,045,000 | +6.6% | 1,657,819 | +7.4% | 0.52% | +12.4% |
| Q3 2016 | $121,026,000 | -19.5% | 1,543,890 | +3.7% | 0.46% | -22.9% |
| Q2 2016 | $150,385,000 | +8.4% | 1,488,957 | +1.8% | 0.59% | +8.0% |
| Q1 2016 | $138,740,000 | +10.6% | 1,462,579 | +8.3% | 0.55% | +8.3% |
| Q4 2015 | $125,398,000 | +184.7% | 1,350,108 | +161.2% | 0.51% | +464.4% |
| Q3 2015 | $44,040,000 | – | 516,843 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |